George P. Canellos
Dana-Farber Cancer Institute
44 Binney Street
Dana 1634
Boston
Name/email consistency: high
- Brentuximab Vedotin and Panobinostat: New Drugs for Hodgkin's Lymphoma--Can They Make One of Medical Oncology's Chemotherapy Success Stories More Successful? Canellos, G.P. J. Clin. Oncol. (2012)
- Treatment of favorable, limited-stage Hodgkin's lymphoma with chemotherapy without consolidation by radiation therapy. Canellos, G.P., Abramson, J.S., Fisher, D.C., LaCasce, A.S. J. Clin. Oncol. (2010)
- Relapsed and refractory Hodgkin's lymphoma: new avenues?. Canellos, G.P. Hematol. Oncol. Clin. North Am. (2007)
- Introduction to a special series of unique entities within the spectrum of large-cell lymphoma. Canellos, G.P. Oncologist (2006)
- Clinical trials in North America. Canellos, G.P. Eur. J. Haematol. Suppl (2005)
- Lymphoma: present and future challenges. Canellos, G.P. Semin. Hematol. (2004)
- Primary systemic treatment of advanced Hodgkin's disease with EVA (etoposide, vinblastine, doxorubicin): 10-year follow-up. Canellos, G.P., Gollub, J., Neuberg, D., Mauch, P., Shulman, L.N. Ann. Oncol. (2003)